PLIVA 459 (Theophylline extended-release 300 mg)
Pill imprint PLIVA 459 has been identified as Theophylline extended-release 300 mg.
Theophylline is used in the treatment of apnea of prematurity; asthma, acute; asthma, maintenance and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PLIVA 459 (Theophylline extended-release 300 mg)
- 300 mg
- 14.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Pliva Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- hypromellose 2208 (100 mPa.s)
hypromellose 2208 (100000 mPa.s)
Theophylline extended-release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...